跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Unasyn - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Unasyn
Approved
STANDARD
Unasyn
Haupt Pharma Latina S.R.L.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
43a53d4c0b0ff881
Company
Haupt Pharma Latina S.R.L.
Type
Standard
Approval Details
Approval Id
43a53d4c0b0ff881
Drug Approval Philippines Name
Unasyn
Product Name
Unasyn
Registration Number
DRP-1923
Brand Name
Unasyn
Generic Name
Ampicillin (As Sodium) + Sulbactam (As Sodium)
Dosage Form
Powder for Injection (I.M./I.V.)
Dosage Strength
500 mg/ 250 mg Per Vial
Manufacturer
Haupt Pharma Latina S.R.L.
Importer
Pfizer, Inc.
Company Detail Path
/organization/haupt-pharma-latina-srl
Importer Detail Path
/organization/pfizer-inc-pleasant-prairie-wisconsin-united-states
Issuance Date
11 February 2021
Expiry Date
02 April 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
43a53d4c0b0ff881
Type
Standard
Back to Philippines FDA Approvals